
In this guide
- 01What Is ISO 15378?
- 02What Is Primary Pharmaceutical Packaging?
- 03Why GMP Matters in Pharmaceutical Packaging
- 04ISO 15378 vs ISO 9001
- 051. Quality Management Responsibilities
- 062. Manufacturing Environment and Hygiene
- 073. Equipment Qualification and Maintenance
- 084. Supplier and Raw Material Controls
- 095. Batch Identification and Traceability
- 106. Process Validation and Quality Control
- 117. Change Control
- 128. Nonconforming Product and Corrective Action
- 13ISO 15378 Documentation Checklist
- 14ISO 15378 Certification Preparation
- 15ISO 15378 and Pharmaceutical Supply Chains
- 16Frequently Asked Questions
- 17Conclusion
Introduction
Pharmaceutical packaging plays an important role in protecting medicinal products from contamination, damage and deterioration.
Packaging materials that come into direct contact with medicines must be manufactured under controlled conditions appropriate to their intended use.
A defect in a container, closure or other primary packaging component can create quality concerns that extend beyond appearance or functionality.
For manufacturers supplying these materials, ISO 15378 provides an internationally recognised quality management framework incorporating Good Manufacturing Practice principles.
Understanding ISO 15378 GMP requirements helps pharmaceutical packaging manufacturers establish appropriate controls, maintain traceability and prepare for independent certification assessment.
This guide explains the standard's application, important implementation areas and the documentation businesses should consider.
What Is ISO 15378?
ISO 15378:2017 is an international standard addressing primary packaging materials for medicinal products.
It specifies particular requirements for applying ISO 9001:2015 with reference to Good Manufacturing Practice.
The standard is intended for organisations involved in designing, manufacturing and supplying primary packaging materials for medicinal products.
The current published edition is ISO 15378:2017, with a climate-action amendment issued in 2024.
Organisations can explore ISO 15378 certification to understand its assessment requirements.
What Is Primary Pharmaceutical Packaging?
Primary packaging refers to packaging materials that are in direct contact with a medicinal product.
Examples may include pharmaceutical bottles, vials, ampoules, blister components, closures and certain flexible packaging materials.
These components can influence product protection and suitability.
For example, a defect in a pharmaceutical container closure could affect the integrity of the packaging system.
A business supplying such materials must understand relevant customer specifications and applicable quality requirements.
Secondary packaging, such as an external carton that does not contact the medicine, is not automatically within the same ISO 15378 primary packaging application.
Why GMP Matters in Pharmaceutical Packaging
Good Manufacturing Practice principles support consistent production under controlled conditions.
For primary packaging manufacturers, relevant concerns include contamination prevention, equipment suitability, process consistency and reliable documentation.
A packaging component should meet agreed specifications and be manufactured using processes appropriate to its intended use.
GMP-related controls help reduce the likelihood of mix-ups, contamination and uncontrolled changes.
They also support reliable investigation when problems occur.
The specific controls necessary depend on the packaging material, manufacturing process and associated risks.
ISO 15378 vs ISO 9001
ISO 15378 incorporates ISO 9001 requirements and adds GMP-related requirements relevant to pharmaceutical primary packaging.
ISO 9001 is a general quality management standard applicable across many industries.
ISO 15378 addresses the specific quality considerations associated with materials used in medicinal packaging.
A company already maintaining an ISO 9001 Quality Management System may have useful existing processes.
However, additional controls may be required for pharmaceutical packaging.
These should be identified through a formal assessment of the applicable standard and customer requirements.
1. Quality Management Responsibilities
Management should establish an effective quality management system supporting consistent manufacturing.
Relevant responsibilities include defining quality objectives, assigning authority and ensuring necessary resources are available.
The organisation should identify applicable customer, statutory and regulatory requirements.
Policies and procedures should reflect the actual manufacturing activities.
For example, a producer of sterile packaging components may require more extensive controls than a manufacturer supplying lower-risk packaging materials.
Management should ensure that quality responsibilities are understood throughout the organisation.
2. Manufacturing Environment and Hygiene
Primary packaging production requires appropriate environmental and hygiene controls.
The level of control should reflect the materials produced and the potential for contamination.
Relevant considerations may include facility cleanliness, material handling, personnel hygiene and environmental monitoring where necessary.
A manufacturer producing pharmaceutical closures, for example, may need to establish controls preventing foreign material contamination.
Cleaning activities should be defined and performed consistently.
Where necessary, the effectiveness of cleaning arrangements should be verified.
3. Equipment Qualification and Maintenance
Manufacturing equipment must be suitable for its intended use.
Poorly maintained machinery can affect packaging dimensions, product integrity and cleanliness.
Businesses should establish appropriate maintenance and inspection arrangements.
Equipment requiring calibration should be controlled accordingly.
Where relevant, processes may also require qualification or validation.
For example, a process producing packaging components with critical dimensional specifications may require evidence that it operates consistently within established limits.
4. Supplier and Raw Material Controls
Packaging quality depends heavily on the materials used in production.
Organisations should establish appropriate supplier selection, qualification and monitoring arrangements.
Raw materials should be checked against relevant specifications.
The degree of supplier control should reflect the potential effect on product quality.
For example, a change in a polymer supplier could affect the characteristics of a pharmaceutical container.
Supplier changes should therefore be evaluated according to their potential consequences.
Purchasing records should support identification and traceability.
5. Batch Identification and Traceability
Traceability is important when investigating defects or customer complaints.
A suitable system helps organisations identify the materials, processes and production batches associated with specific packaging components.
For example, if a defect is discovered in a batch of pharmaceutical closures, the manufacturer should be able to determine the affected production records.
Traceability may involve raw material lot numbers, manufacturing dates, equipment information and inspection results.
The required detail depends on applicable requirements and product risks.
Accurate records can support effective investigation and containment.
6. Process Validation and Quality Control
Where manufacturing outputs cannot be fully verified through subsequent inspection, appropriate process validation may be necessary.
Validation provides evidence that the process can consistently achieve intended results.
Manufacturers should identify relevant process parameters and product specifications.
Quality-control activities may include dimensional checks, visual inspection, material testing and other product-specific evaluations.
The exact controls should be established according to product requirements.
Inspection results should be reviewed and retained where necessary.
7. Change Control
Changes to materials, suppliers, equipment or production methods can affect packaging quality.
A structured change-control process helps identify these consequences before implementation.
For example, replacing a production mould may affect the dimensions of a packaging component.
The organisation should assess whether additional testing, qualification or customer approval is needed.
Changes should be appropriately authorised and documented.
Where relevant, customers should be informed according to contractual or regulatory requirements.
8. Nonconforming Product and Corrective Action
Manufacturers should establish procedures for identifying and controlling nonconforming materials.
Affected products may require segregation, evaluation and appropriate disposition.
For example, packaging components that fail dimensional inspection should not be released without an appropriate decision.
Where defects occur repeatedly, the organisation should investigate underlying causes.
Corrective actions should address the actual problem and be evaluated for effectiveness.
Complaint information and manufacturing data can support these investigations.
ISO 15378 Documentation Checklist
Document or record | Main purpose |
Quality policy and objectives | Establish quality direction |
Product specifications | Define packaging requirements |
Supplier qualification records | Support material control |
Manufacturing instructions | Establish consistent processes |
Cleaning and hygiene records | Demonstrate operational controls |
Equipment maintenance records | Support equipment suitability |
Validation records | Demonstrate process capability where required |
Batch manufacturing records | Support traceability |
Inspection and testing records | Demonstrate conformity |
Change-control records | Evaluate manufacturing changes |
Complaint records | Support investigation |
Internal audit reports | Assess QMS implementation |
The full documentation requirements should be established from the applicable ISO 15378 text and relevant customer obligations.
ISO 15378 Certification Preparation
A practical preparation process begins with reviewing the current quality management system.
Management should identify gaps against ISO 15378 and determine whether additional GMP-related controls are required.
The organisation should then update relevant procedures, train employees and implement the necessary arrangements.
Operating evidence should be gathered through normal production activities.
An internal audit can evaluate the effectiveness of the system.
Management review should assess performance and necessary improvements.
An external certification body can then evaluate conformity within the agreed scope.
The time required depends on manufacturing complexity and existing quality management maturity.
ISO 15378 and Pharmaceutical Supply Chains
Pharmaceutical manufacturers often require strong supplier controls because packaging quality can affect medicinal product quality.
ISO 15378 may support supplier assurance by demonstrating the use of structured quality and GMP-related processes.
However, certification should not be treated as a substitute for supplier qualification, product testing or applicable pharmaceutical regulations.
Organisations should ensure that their arrangements reflect the specific packaging materials supplied.
Businesses can also review London Cert's healthcare and pharmaceutical certification guidance for related quality management considerations.
Frequently Asked Questions
What is ISO 15378 used for?
ISO 15378 establishes quality management and GMP-related requirements for manufacturers and suppliers of primary packaging materials for medicinal products.
Is ISO 15378 based on ISO 9001?
Yes. ISO 15378:2017 incorporates ISO 9001:2015 requirements alongside additional GMP-related provisions.
Is ISO 15378 applicable to secondary packaging?
Its primary application is to primary packaging materials for medicinal products. Organisations should review the precise scope before assuming applicability to other packaging activities.
Is ISO 15378 certification mandatory worldwide?
Requirements vary according to markets, products and customer obligations. Certification is not universally mandatory for every packaging business.
Can an existing ISO 9001 company pursue ISO 15378?
Yes. An existing ISO 9001 system may provide a foundation, but applicable ISO 15378-specific requirements must still be addressed.
Conclusion
Understanding ISO 15378 GMP requirements helps pharmaceutical packaging manufacturers establish more reliable quality controls.
Effective implementation requires attention to hygiene, supplier management, manufacturing consistency, traceability, validation and change control.
The objective is to ensure that packaging materials are produced under conditions appropriate to their intended medicinal use.
For guidance on scope and certification assessment, explore London Cert's ISO 15378 services.
London Cert Team
Verified Lead AuditorWritten and peer-reviewed by London Cert's senior assessment directorate. London Cert Ltd is an independent UK-registered registrar officially accredited by UASL (United Accreditation Services Limited) for management system certifications worldwide.
